Delivery Order SPE2DB22D2211-SPE2DB24FPAD7
Award Date
7/26/24
Potential Completion Date
7/29/24
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of LOTREL 10-20 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The $31,072.83 Firm Fixed Price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 26, 2024 with a completion date of July 29, 2024. The contract is a Delivery Order and is not associated with any set-aside designation. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of LOTREL 10-20 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The contract has a ceiling value of $19,585.71 and is a Firm Fixed Price Delivery Order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of September 17, 2024 and was awarded on September 16, 2024. The contract was not set aside for any specific business...
This federal contract award is for the delivery of LOTREL 10-20 MG CAPSULE 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $13,460.19 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with an ultimate completion date of August 29, 2024. The contract was awarded under the DLA's Troop Support Medical Indefinite Delivery Contract, a large medical commodities vehicle valued up to $999,999,999 through December 2025,...
This federal contract award is for the delivery of LOTREL 5-20 MG CAPSULE 100S to the Defense Logistics Agency (DLA), a defense agency. The $4,543.36 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 13, 2025 with a completion date of March 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This federal contract award is for the delivery of LOTREL 10-20 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $8,584.99. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
This federal contract award is for the delivery of LOTREL 5-20 MG CAPSULE 100S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The award, valued at $1,942.32, was made to the Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of June 17, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of 4554830277 LOTREL 10-20 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The $2,708.77 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on September 20, 2021 with a completion date of September 21, 2021. Amerisourcebergen is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans'...
This federal contract award is for the delivery of LOTREL 10-20 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The $9,966.33 firm fixed-price delivery order was issued under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc., doing business as Amerisourcebergen, holds with the DLA Troop Support Medical. This comprehensive IDC enables Amerisourcebergen to efficiently supply a wide range of pharmaceutical products and medical supplies,...
This federal contract award is for the delivery of LOTREL 10-20 MG CAPSULE 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. The contract, valued at $2,462.96, is a delivery order with a firm fixed price. It has an ultimate completion date of March 11, 2024. The contract is not associated with any set-aside...
This federal contract award is for the delivery of LOTREL 10-20 mg capsules in 100-count bottles to the Defense Logistics Agency (DLA). The $6,184.11 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...